Literature DB >> 27687671

Identification of small molecules that bind to the mitochondrial protein mitoNEET.

Werner J Geldenhuys1, Heather M Yonutas2, Daniel L Morris3, Patrick G Sullivan2, Altaf S Darvesh4, Thomas C Leeper3.   

Abstract

MitoNEET (CISD1) is a 2Fe-2S iron-sulfur cluster protein belonging to the zinc-finger protein family. Recently mitoNEET has been shown to be a major role player in the mitochondrial function associated with metabolic type diseases such as obesity and cancers. The anti-diabetic drug pioglitazone and rosiglitazone were the first identified ligands to mitoNEET. Since little is known about structural requirements for ligand binding to mitoNEET, we screened a small set of compounds to gain insight into these requirements. We found that the thiazolidinedione (TZD) warhead as seen in rosiglitazone was not an absolutely necessity for binding to mitoNEET. These results will aid in the development of novel compounds that can be used to treat mitochondrial dysfunction seen in several diseases.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Bioenergetics; Glitazones; Mitochondria; Type II diabetes

Mesh:

Substances:

Year:  2016        PMID: 27687671      PMCID: PMC5482219          DOI: 10.1016/j.bmcl.2016.09.009

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  15 in total

1.  Structure-based design of a thiazolidinedione which targets the mitochondrial protein mitoNEET.

Authors:  Werner J Geldenhuys; Max O Funk; Kendra F Barnes; Richard T Carroll
Journal:  Bioorg Med Chem Lett       Date:  2010-01-04       Impact factor: 2.823

2.  Novel ligands that target the mitochondrial membrane protein mitoNEET.

Authors:  Robert M Bieganski; Martin L Yarmush
Journal:  J Mol Graph Model       Date:  2011-04-13       Impact factor: 2.518

3.  MitoNEET is an iron-containing outer mitochondrial membrane protein that regulates oxidative capacity.

Authors:  Sandra E Wiley; Anne N Murphy; Stuart A Ross; Peter van der Geer; Jack E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-21       Impact factor: 11.205

4.  A scaffold hopping approach to identify novel monoamine oxidase B inhibitors.

Authors:  Werner J Geldenhuys; Max O Funk; Cornelis J Van der Schyf; Richard T Carroll
Journal:  Bioorg Med Chem Lett       Date:  2011-12-16       Impact factor: 2.823

5.  Crystal structure of human mitoNEET reveals distinct groups of iron sulfur proteins.

Authors:  Jinzhong Lin; Tao Zhou; Keqiong Ye; Jinfeng Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-31       Impact factor: 11.205

6.  MitoNEET is a uniquely folded 2Fe 2S outer mitochondrial membrane protein stabilized by pioglitazone.

Authors:  Mark L Paddock; Sandra E Wiley; Herbert L Axelrod; Aina E Cohen; Melinda Roy; Edward C Abresch; Dominique Capraro; Anne N Murphy; Rachel Nechushtai; Jack E Dixon; Patricia A Jennings
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-31       Impact factor: 11.205

Review 7.  mitoNEET as a novel drug target for mitochondrial dysfunction.

Authors:  Werner J Geldenhuys; Thomas C Leeper; Richard T Carroll
Journal:  Drug Discov Today       Date:  2014-05-09       Impact factor: 7.851

8.  Glibenclamide interferes with mitochondrial bioenergetics by inducing changes on membrane ion permeability.

Authors:  Maria A S Fernandes; Maria S Santos; António J M Moreno; Gunars Duburs; Catarina R Oliveira; Joaquim A F Vicente
Journal:  J Biochem Mol Toxicol       Date:  2004       Impact factor: 3.642

9.  Identification of a novel mitochondrial protein ("mitoNEET") cross-linked specifically by a thiazolidinedione photoprobe.

Authors:  Jerry R Colca; William G McDonald; Daniel J Waldon; Joseph W Leone; June M Lull; Carol A Bannow; Eric T Lund; W Rodney Mathews
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-10-21       Impact factor: 4.310

10.  Metformin directly acts on mitochondria to alter cellular bioenergetics.

Authors:  Sylvia Andrzejewski; Simon-Pierre Gravel; Michael Pollak; Julie St-Pierre
Journal:  Cancer Metab       Date:  2014-08-28
View more
  13 in total

1.  Binding of thiazolidinediones to the endoplasmic reticulum protein nutrient-deprivation autophagy factor-1.

Authors:  Werner J Geldenhuys; Robert Skolik; Mary E Konkle; Michael A Menze; Timothy E Long; Aaron R Robart
Journal:  Bioorg Med Chem Lett       Date:  2019-02-01       Impact factor: 2.823

2.  Bioenergetic restoration and neuroprotection after therapeutic targeting of mitoNEET: New mechanism of pioglitazone following traumatic brain injury.

Authors:  Heather M Yonutas; W Brad Hubbard; Jignesh D Pandya; Hemendra J Vekaria; Werner J Geldenhuys; Patrick G Sullivan
Journal:  Exp Neurol       Date:  2020-02-10       Impact factor: 5.330

3.  High-content screen using zebrafish (Danio rerio) embryos identifies a novel kinase activator and inhibitor.

Authors:  Werner J Geldenhuys; Sadie A Bergeron; Jackie E Mullins; Rowaa Aljammal; Briah L Gaasch; Wei-Chi Chen; June Yun; Lori A Hazlehurst
Journal:  Bioorg Med Chem Lett       Date:  2017-02-28       Impact factor: 2.823

4.  The mitochondrial outer membrane protein mitoNEET is a redox enzyme catalyzing electron transfer from FMNH2 to oxygen or ubiquinone.

Authors:  Yiming Wang; Aaron P Landry; Huangen Ding
Journal:  J Biol Chem       Date:  2017-05-01       Impact factor: 5.157

5.  MitoNEET (CISD1) Knockout Mice Show Signs of Striatal Mitochondrial Dysfunction and a Parkinson's Disease Phenotype.

Authors:  Werner J Geldenhuys; Stanley A Benkovic; Li Lin; Heather M Yonutas; Samuel D Crish; Patrick G Sullivan; Altaf S Darvesh; Candice M Brown; Jason R Richardson
Journal:  ACS Chem Neurosci       Date:  2017-09-27       Impact factor: 4.418

6.  Exploring the FMN binding site in the mitochondrial outer membrane protein mitoNEET.

Authors:  Homyra Tasnim; Aaron P Landry; Chelsey R Fontenot; Huangen Ding
Journal:  Free Radic Biol Med       Date:  2020-05-20       Impact factor: 7.376

Review 7.  Rescuing mitochondria in traumatic brain injury and intracerebral hemorrhages - A potential therapeutic approach.

Authors:  Meenakshi Ahluwalia; Manish Kumar; Pankaj Ahluwalia; Scott Rahimi; John R Vender; Raghavan P Raju; David C Hess; Babak Baban; Fernando L Vale; Krishnan M Dhandapani; Kumar Vaibhav
Journal:  Neurochem Int       Date:  2021-09-22       Impact factor: 3.921

8.  Targeting mitoNEET with pioglitazone for therapeutic neuroprotection after spinal cord injury.

Authors:  Alexander G Rabchevsky; Samir P Patel; Patrick G Sullivan
Journal:  Neural Regen Res       Date:  2017-11       Impact factor: 5.135

9.  Phylogenetic analysis of the CDGSH iron-sulfur binding domain reveals its ancient origin.

Authors:  Soham Sengupta; Rachel Nechushtai; Patricia A Jennings; Jose' N Onuchic; Pamela A Padilla; Rajeev K Azad; Ron Mittler
Journal:  Sci Rep       Date:  2018-03-19       Impact factor: 4.379

10.  Crystal structure of the mitochondrial protein mitoNEET bound to a benze-sulfonide ligand.

Authors:  Werner J Geldenhuys; Timothy E Long; Pushkar Saralkar; Toshio Iwasaki; Raisa A A Nuñez; Rajesh R Nair; Mary E Konkle; Michael A Menze; Mark V Pinti; John M Hollander; Lori A Hazlehurst; Aaron R Robart
Journal:  Commun Chem       Date:  2019-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.